| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kate Hanneman, Gauri R Karur, Syed Wasim, Rachel M Wald, Robert M Iwanochko, Chantal F More. Left Ventricular Hypertrophy and Late Gadolinium Enhancement at Cardiac MRI Are Associated with Adverse Cardiac Events in Fabry Disease. Radiology. vol 294. issue 1. 2020-04-20. PMID:31660802. |
left ventricular hypertrophy and late gadolinium enhancement at cardiac mri are associated with adverse cardiac events in fabry disease. |
2020-04-20 |
2023-08-13 |
Not clear |
| Sergey Moiseev, Ekaterina Karovaikina, Alexey Moiseev, Nikolai Bulanov, Victor Fomi. Strategies of Screening for Fabry Disease in Patients with Unexplained Left Ventricular Hypertrophy. Mayo Clinic proceedings. vol 94. issue 8. 2019-12-30. PMID:31378240. |
strategies of screening for fabry disease in patients with unexplained left ventricular hypertrophy. |
2019-12-30 |
2023-08-13 |
Not clear |
| Darrell B Newman, Michael J Ackerma. In reply-Strategies of Screening for Fabry Disease in Patients With Unexplained Left Ventricular Hypertrophy. Mayo Clinic proceedings. vol 94. issue 8. 2019-12-30. PMID:31378242. |
in reply-strategies of screening for fabry disease in patients with unexplained left ventricular hypertrophy. |
2019-12-30 |
2023-08-13 |
Not clear |
| Jonas Müntze, Tim Salinger, Daniel Gensler, Christoph Wanner, Peter Nordbec. Treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of Fabry disease with chaperone therapy. European heart journal. vol 39. issue 20. 2019-11-18. PMID:29452394. |
treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of fabry disease with chaperone therapy. |
2019-11-18 |
2023-08-13 |
Not clear |
| Martin S Maron, Winnie Xin, Katherine B Sims, Rita Butler, Tammy S Haas, Ethan J Rowin, Robert J Desnick, Barry J Maro. Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy. The American journal of medicine. vol 131. issue 2. 2019-06-26. PMID:28943383. |
identification of fabry disease in a tertiary referral cohort of patients with hypertrophic cardiomyopathy. |
2019-06-26 |
2023-08-13 |
Not clear |
| Martin S Maron, Winnie Xin, Katherine B Sims, Rita Butler, Tammy S Haas, Ethan J Rowin, Robert J Desnick, Barry J Maro. Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy. The American journal of medicine. vol 131. issue 2. 2019-06-26. PMID:28943383. |
fabry disease is an x-linked lysosomal storage disorder caused by the deficient activity of α-galactosidase a due to mutations in the gla gene, which may be associated with increased left ventricular wall thickness and mimic the morphologic features of hypertrophic cardiomyopathy. |
2019-06-26 |
2023-08-13 |
Not clear |
| Albert Hagège, Patricia Réant, Gilbert Habib, Thibaud Damy, Gilles Barone-Rochette, Gilles Soulat, Erwan Donal, Dominique P Germai. Fabry disease in cardiology practice: Literature review and expert point of view. Archives of cardiovascular diseases. vol 112. issue 4. 2019-06-10. PMID:30826269. |
in hypertrophic cardiomyopathy cohorts, up to 1% of patients have been diagnosed with fabry disease. |
2019-06-10 |
2023-08-13 |
Not clear |
| Woo-Shik Kim, Hyun Soo Kim, Jinho Shin, Jong Chun Park, Han-Wook Yoo, Toshihiro Takenaka, Chuwa Te. Prevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy. Journal of Korean medical science. vol 34. issue 7. 2019-05-31. PMID:30804731. |
prevalence of fabry disease in korean men with left ventricular hypertrophy. |
2019-05-31 |
2023-08-13 |
Not clear |
| Woo-Shik Kim, Hyun Soo Kim, Jinho Shin, Jong Chun Park, Han-Wook Yoo, Toshihiro Takenaka, Chuwa Te. Prevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy. Journal of Korean medical science. vol 34. issue 7. 2019-05-31. PMID:30804731. |
previous studies identified many cases of fabry disease among men with left ventricular hypertrophy (lvh). |
2019-05-31 |
2023-08-13 |
Not clear |
| Darrell B Newman, William R Miranda, Dietrich Matern, Dawn S Peck, Jeffrey B Geske, Joseph J Maleszewski, Steve R Ommen, Michael J Ackerma. Cost Efficacy of α-Galactosidase A Enzyme Screening for Fabry Disease. Mayo Clinic proceedings. vol 94. issue 1. 2019-05-24. PMID:30611458. |
the prevalence of fabry disease (fd) in adult patients with suspected hypertrophic cardiomyopathy (hcm) has been reported between 0.3% and 4%. |
2019-05-24 |
2023-08-13 |
Not clear |
| Hassan Hazari, Israel Belenkie, Albert Kryski, James A White, Gavin Y Oudit, Richard Thompson, Tak Fung, Navdeep Dehar, Aneal Kha. Comparison of Cardiac Magnetic Resonance Imaging and Echocardiography in Assessment of Left Ventricular Hypertrophy in Fabry Disease. The Canadian journal of cardiology. vol 34. issue 8. 2019-05-03. PMID:29935990. |
comparison of cardiac magnetic resonance imaging and echocardiography in assessment of left ventricular hypertrophy in fabry disease. |
2019-05-03 |
2023-08-13 |
Not clear |
| Hassan Hazari, Israel Belenkie, Albert Kryski, James A White, Gavin Y Oudit, Richard Thompson, Tak Fung, Navdeep Dehar, Aneal Kha. Comparison of Cardiac Magnetic Resonance Imaging and Echocardiography in Assessment of Left Ventricular Hypertrophy in Fabry Disease. The Canadian journal of cardiology. vol 34. issue 8. 2019-05-03. PMID:29935990. |
cardiac hypertrophy in fabry disease can be assessed using the left ventricular mass index (lvmi) with either echocardiography (lvmi-echo) or magnetic resonance imaging (lvmi-cmr). |
2019-05-03 |
2023-08-13 |
Not clear |
| Ravi Vijapurapu, Sabrina Nordin, Shanat Baig, Boyang Liu, Stefania Rosmini, Joao Augusto, Michel Tchan, Derralynn A Hughes, Tarekegn Geberhiwot, James C Moon, Richard Paul Steeds, Rebecca Kozo. Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease. Heart (British Cardiac Society). vol 105. issue 6. 2019-05-02. PMID:30282640. |
global longitudinal strain, myocardial storage and hypertrophy in fabry disease. |
2019-05-02 |
2023-08-13 |
Not clear |
| Kenichi Hongo, Keiichi Ito, Taro Date, Ikuko Anan, Yasunori Inoue, Satoshi Morimoto, Kazuo Ogawa, Makoto Kawai, Hiroshi Kobayashi, Masahisa Kobayashi, Hiroyuki Ida, Toya Ohashi, Ikuo Taniguchi, Michihiro Yoshimura, Yoshikatsu Et. The beneficial effects of long-term enzyme replacement therapy on cardiac involvement in Japanese Fabry patients. Molecular genetics and metabolism. vol 124. issue 2. 2019-03-13. PMID:29747997. |
fabry disease is a hereditary disorder that occurs due to the reduction or absence of alpha-galactosidase a activity, which leads to cardiac involvement including left ventricular hypertrophy (lvh). |
2019-03-13 |
2023-08-13 |
Not clear |
| María Cristina Saccheri, Tomás Francisco Cianciulli, Wilde Challapa Licidio, Jorge A Lax, Martín A Beck, Luis A Morita, Juan A Gagliard. Comparison of left atrial size and function in hypertrophic cardiomyopathy and in Fabry disease with left ventricular hypertrophy. Echocardiography (Mount Kisco, N.Y.). vol 35. issue 5. 2018-11-05. PMID:29457264. |
comparison of left atrial size and function in hypertrophic cardiomyopathy and in fabry disease with left ventricular hypertrophy. |
2018-11-05 |
2023-08-13 |
Not clear |
| María Cristina Saccheri, Tomás Francisco Cianciulli, Wilde Challapa Licidio, Jorge A Lax, Martín A Beck, Luis A Morita, Juan A Gagliard. Comparison of left atrial size and function in hypertrophic cardiomyopathy and in Fabry disease with left ventricular hypertrophy. Echocardiography (Mount Kisco, N.Y.). vol 35. issue 5. 2018-11-05. PMID:29457264. |
fabry disease (fd) and hypertrophic cardiomyopathy (hcm) are two diseases with a different pathophysiology, both cause left ventricular hypertrophy (lvh) and myocardial fibrosis. |
2018-11-05 |
2023-08-13 |
Not clear |
| Olga Azevedo, Miguel Gago, Gabriel Miltenberger-Miltenyi, Paulo Gaspar, Nuno Sousa, Damião Cunh. Mild Left Ventricular Hypertrophy Unravels a Novel Nonsense Mutation of the GLA Gene Associated with the Classical Phenotype of Fabry Disease. Cardiology. vol 137. issue 2. 2018-08-13. PMID:28152533. |
mild left ventricular hypertrophy unravels a novel nonsense mutation of the gla gene associated with the classical phenotype of fabry disease. |
2018-08-13 |
2023-08-13 |
Not clear |
| Olga Azevedo, Miguel Gago, Gabriel Miltenberger-Miltenyi, Paulo Gaspar, Nuno Sousa, Damião Cunh. Mild Left Ventricular Hypertrophy Unravels a Novel Nonsense Mutation of the GLA Gene Associated with the Classical Phenotype of Fabry Disease. Cardiology. vol 137. issue 2. 2018-08-13. PMID:28152533. |
this report highlights that (i) fabry disease diagnosis should be considered in all cases of unexplained left ventricular hypertrophy (lvh), even in its milder forms; (ii) a complete evaluation of patients with unexplained lvh is important to find diagnostic red flags of treatable causes of lvh, such as fabry disease; (iii) cascade family screening is paramount to the earlier diagnosis and treatment of other affected family members; and (iv) the fabry disease phenotype is highly variable in heterozygote females, even within the same family. |
2018-08-13 |
2023-08-13 |
Not clear |
| Ryuichiro Ana. Fabry Disease and/or Hypertrophic Cardiomyopathy. International heart journal. vol 58. issue 3. 2018-08-06. PMID:28539575. |
fabry disease and/or hypertrophic cardiomyopathy. |
2018-08-06 |
2023-08-13 |
Not clear |
| Toshinori Yuasa, Toshihiro Takenaka, Koji Higuchi, Nami Uchiyama, Yoshihisa Horizoe, Hideto Cyaen, Naoko Mizukami, Kunitsugu Takasaki, Akira Kisanuki, Masaaki Miyata, Mitsuru Ohish. Fabry disease. Journal of echocardiography. vol 15. issue 4. 2018-07-17. PMID:28674962. |
cardiac manifestations in fabry disease are initially symmetrical and concentric left ventricular hypertrophy, and later progressive cardiac dysfunction with localized thinning of the basal posterior wall. |
2018-07-17 |
2023-08-13 |
Not clear |